Showing results (11-20 of 637) with videos related to
Sort By:
Pageof 64
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patientsT Schroeder, L Ruf, A Bernhardt, et al.Annals of Hematology|November 21, 2022
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blastsA Kasprzak, C Assadi, K Nachtkamp, et al.Leukemia & Lymphoma|July 16, 2005
The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomideC Strupp, U Germing, M Aivado, et al.Der Radiologe|April 20, 2002
[Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy]A Scherer, C Strupp, H J Wittsack, et al.Leukemia Research|December 5, 2021
The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-TJ Kaivers, J Peters, C Rautenberg, et al.Leukemia Research|December 3, 2014
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemiasE Schuler, M Schroeder, J Neukirchen, et al.International Journal of Oncology|May 10, 2011
Expression of cd34 and p-glycoprotein - prognostic-significance in primary myelodysplastic syndromesV Runde, U Germing, C AulInternational Journal of Hematology|August 16, 2001
Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statisticsC Aul, A Giagounidis, U GermingLeukemia & Lymphoma|September 14, 2004
Risk assessment in chronic myelomonocytic leukemia (CMML)U Germing, A Kündgen, N GattermannPageof 64